- The following is a list of metrics included in A Guidebook to Pharma Brand Optimization: Lifecycle Management Strategy. While this list is not inclusive of all the data in the report, it summarizes the main categories and types of data included in each chapter.
- Chapter 1:
- Companies’ LCM Structures
- Dedicated Lifecycle Management Team
- Dedicated Lifecycle Management Team Reports to Which Department
- Departments Responsible for LCM when No Dedicated Team Exists
- Company F’s LCM Structure
- Title of Those Responsible for Spearheading LCM
- Other Functions Involved in LCM During Various Time Periods
- LCM Budgets Tied to Individual Brands
- Funding of LCM Budgets
- Lifecycle Management Ratings
- Important Factors to Have a Successful LCM Effort
- Areas with Greatest Room for Improvement
- Importance of Criteria in Assessing LCM Tactics
- LCM Success Measurements
- Chapter 2:
- Pre-Launch LCM Tactical Timeline
- Pre-Launch LCM Strategy Investment Levels
- Average Time to Implement Pre-Launch LCM Strategies
- Pre-Launch LCM Strategy Time to Implement vs. Return on Investment
- Pre-Launch LCM Strategy Return on Investment
- There are five LCM tactics examined in this chapter, including divestitures, new formulations/delivery systems, strategic alliances/licensing, publications strategy and contracting with large volume purchasers. Within each LCM tactic profile there are the following graphics:
- Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
- Planning for Tactic Begins
- Implementation for Tactic Begins
- Effectiveness of LCM Tactic
- Chapter 3:
- Peak (Launch until two years prior to US patent expiration) LCM Tactical Timeline
- Peak LCM Strategy Investment Levels
- Average Time to Implement Peak LCM Strategies
- Peak LCM Strategy Time to Implement vs. Return on Investment
- Peak LCM Strategy Return on Investment
- There are six LCM tactics examined in this chapter: strategic pricing, new dosing frequency, new dosing strength, new indication, CRM/disease management, market repositioning and repurposing. Within each LCM tactic profile there are the following graphics:
- Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
- Planning for Tactic Begins
- Implementation for Tactic Begins
- Effectiveness of LCM Tactic
- Chapter 4:
- Mature (Two years prior to US patent expiration and beyond) LCM Tactical Timeline
- Mature LCM Strategy Investment Levels
- Average Time to Implement Mature LCM Strategies
- Mature LCM Strategy Time to Implement vs. Return on Investment
- Mature LCM Strategy Return on Investment
- There are six LCM tactics examined in this chapter including: pediatric indications, new combinations, next generation product, patent litigation, branded generics, Rx-to-OTC and removal from market. Within each LCM tactic profile there are the following graphics:
- Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
- Planning for Tactic Begins
- Implementation for Tactic Begins
- Effectiveness of LCM Tactic
- Chapter 5:
- There are seven individual brand LCM profiles, most of which contain the following metrics and graphics.
- Brand Overview: Peak Sales, Therapeutic Area, Company Size, Brand Erosion, Number of Years of Patent Protection on US Market
- Competitive Outlook: Number of Generic and Branded Competitors
- Greatest Threats to Brand
- LCM Tactical Approach
- LCM Tactic Timelines: When Planning for Tactic Begins
- Annual LCM Strategy Investments
- LCM Strategy Annual Investments by Time Period
- LCM Headcount Support
- Percentage of Brand’s Marketing Budget Allocated to LCM
- LCM Strategy Investments, Returns and Returns on Investment Percentages
- LCM Strategies’ Average Returns Per Dollar Invested
|
0 items
